Page last updated: 2024-10-30

lansoprazole and Diabetic Glomerulosclerosis

lansoprazole has been researched along with Diabetic Glomerulosclerosis in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Research Excerpts

ExcerptRelevanceReference
"Diabetic nephropathy was induced with a single injection of streptozotocin (STZ, 45 mg/kg, i."1.43Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in wistar rats. ( Aggarwal, N; Jain, UK; Kaur, J; Kaur, R; Sodhi, RK, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Mostafa, DK1
Khedr, MM1
Barakat, MK1
Abdellatif, AA1
Elsharkawy, AM1
Kaur, R1
Sodhi, RK1
Aggarwal, N1
Kaur, J1
Jain, UK1

Other Studies

2 other studies available for lansoprazole and Diabetic Glomerulosclerosis

ArticleYear
Autophagy blockade mechanistically links proton pump inhibitors to worsened diabetic nephropathy and aborts the renoprotection of metformin/enalapril.
    Life sciences, 2021, Jan-15, Volume: 265

    Topics: Albuminuria; Animals; Autophagy; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High

2021
Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in wistar rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2016, Volume: 389, Issue:1

    Topics: Animals; Blood Glucose; Blood Urea Nitrogen; Brain; Cholesterol; Creatinine; Diabetes Mellitus, Expe

2016